Managers / Q4 2025 · view latest →
BRANDYWINE MANAGERS, LLC
CIK 0001135121 · 7234 LANCASTER PIKE, HOCKESSIN, DE, 19707 · 302-234-5705
Summary
Brandywine Managers, LLC reported $202M in U.S.-listed holdings across 38 positions for Q4 2025.
The portfolio is heavily concentrated: CPB alone accounts for 45.9% of reported value.
Compared with Q3 2025, the fund opened 1 new position and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 79.0% · $160M
- ETP · 20.5% · $42M
- ADR · 0.5% · $928,979
Quarter-over-Quarter Changes full breakdown →
vs Q3 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CPBTHE CAMPBELLS COMPANY | NEW | +3.33M | 3.33M | +$93M | $93M |
| NOWSERVICENOW INC | ADDED | +3.6K | 4.5K | −$137,817 | $683,993 |
| GPCRSTRUCTURE THERAPEUTICS INC | ADDED | +2.3K | 13.4K | +$619,383 | $928,979 |
| FIGFIGMA INC | ADDED | +2.7K | 17.1K | −$110,826 | $640,148 |
| OKTAOKTA INC | TRIMMED | −300 | 3.9K | −$47,954 | $338,011 |
| ISRGINTUITIVE SURGICAL INC | HELD | −100 | 2.2K | +$214,742 | $1M |
| ALNYALNYLAM PHARMACEUTICALS INC | HELD | −100 | 3.6K | −$256,710 | $1M |
| NTRANATERA INC | HELD | −200 | 15.6K | +$1M | $4M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | CPBTHE CAMPBELLS COMPANYhistory → | COM | 45.88% | $93M | 3.33M |
| 2 | ACWIISHARES TRhistory → | MSCI ACWI ETF | 20.54% | $42M | 293.7K |
| 3 | PATHUIPATH INChistory → | CL A | 8.18% | $17M | 1.01M |
| 4 | CRWDCROWDSTRIKE HLDGS INChistory → | CL A | 7.50% | $15M | 32.4K |
| 5 | NVDANVIDIA CORPORATIONhistory → | COM | 1.79% | $4M | 19.4K |
| 6 | NTRANATERA INChistory → | COM | 1.77% | $4M | 15.6K |
| 7 | UBERUBER TECHNOLOGIES INChistory → | COM | 1.19% | $2M | 29.4K |
| 8 | NETCLOUDFLARE INC | CL A COM | 0.97% | $2M | 9.9K |
| 9 | ZSZSCALER INC | COM | 0.93% | $2M | 8.4K |
| 10 | CRMSALESFORCE INC | COM | 0.91% | $2M | 6.9K |
| 11 | AMDADVANCED MICRO DEVICES INC | COM | 0.75% | $2M | 7.1K |
| 12 | MDBMONGODB INC | CL A | 0.73% | $1M | 3.5K |
| 13 | ALNYALNYLAM PHARMACEUTICALS INC | COM | 0.71% | $1M | 3.6K |
| 14 | DDOGDATADOG INC | CL A COM | 0.68% | $1M | 10.1K |
| 15 | ISRGINTUITIVE SURGICAL INC | COM NEW | 0.61% | $1M | 2.2K |
| 16 | IOTSAMSARA INC | COM CL A | 0.54% | $1M | 31.0K |
| 17 | SNOWSNOWFLAKE INC | COM SHS | 0.54% | $1M | 5.0K |
| 18 | GHGUARDANT HEALTH INC | COM | 0.51% | $1M | 10.1K |
| 19 | MAMASTERCARD INCORPORATED | CL A | 0.50% | $1M | 1.8K |
| 20 | GPCRSTRUCTURE THERAPEUTICS INC | SPONSORED ADS | 0.46% | $928,979 | 13.4K |
| 21 | RNAGBPAVIDITY BIOSCIENCES INC | COM | 0.45% | $904,510 | 12.5K |
| 22 | LLYELI LILLY & CO | COM | 0.37% | $749,052 | 697 |
| 23 | NOWSERVICENOW INC | COM | 0.34% | $683,993 | 4.5K |
| 24 | TWSTTWIST BIOSCIENCE CORP | COM | 0.33% | $665,168 | 21.0K |
| 25 | FIGFIGMA INC | CLASS A COM STK | 0.32% | $640,148 | 17.1K |
| 26 | VEEVVEEVA SYS INC | CL A COM | 0.30% | $615,892 | 2.8K |
| 27 | KVYOKLAVIYO INC | COM SER A | 0.28% | $564,458 | 17.4K |
| 28 | BEAMBEAM THERAPEUTICS INC | COM | 0.26% | $515,758 | 18.6K |
| 29 | HTFLHEARTFLOW INC | COM | 0.24% | $488,962 | 16.8K |
| 30 | VKTXVIKING THERAPEUTICS INC | COM | 0.21% | $432,749 | 12.3K |
| 31 | PDPAGERDUTY INC | COM | 0.20% | $400,078 | 30.5K |
| 32 | SDGRSCHRODINGER INC | COM | 0.18% | $373,442 | 20.9K |
| 33 | OKTAOKTA INC | CL A | 0.17% | $338,011 | 3.9K |
| 34 | TWLOTWILIO INC | CL A | 0.17% | $335,260 | 2.4K |
| 35 | RLAYRELAY THERAPEUTICS INC | COM | 0.16% | $325,109 | 38.4K |
| 36 | TXG10X GENOMICS INC | CL A COM | 0.15% | $308,879 | 18.9K |
| 37 | MRNAMODERNA INC | COM | 0.14% | $280,450 | 9.5K |
| 38 | ABCLABCELLERA BIOLOGICS INC | COM | 0.05% | $97,429 | 28.5K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $170M | 40 | May 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $202M | 38 | Feb 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $104M | 37 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $101M | 36 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $83M | 35 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $95M | 37 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $93M | 35 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $95M | 36 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $101M | 40 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $91M | 42 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $59M | 38 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $151M | 48 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $141M | 48 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $29M | 37 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $30M | 39 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $41M | 42 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $58M | 42 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $88M | 43 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $96M | 44 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $88M | 45 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $75M | 46 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $73M | 42 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $53M | 40 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $24M | 40 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $284M | 38 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $334M | 49 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $299M | 48 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $267M | 48 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $250M | 48 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $212M | 46 | Feb 12, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 6 additional managers.
- GARDNER RUSSO & QUINN LLC028-02635
- PARAMETRIC PORTFOLIO ASSOCIATES LLC028-04558
- Aperio Group, LLC028-11964
- BrandyTrust Global Partners, LP028-18174
- ABANCO INVESTORS LTD., LLC028-06287
- RDZ Family, LLC028-23262
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.